Amarin Corp Plc (AMRN)

[bidmark]

Somebody needs to call Jack Bauer.....


Maybe we need the NSC to connect the dots here - at least for me - because I don't understand how the FDA would change the OB so that the active ingredient in Vascepa is also the active ingredient in Lovaza. Wouldn't this change the formulation of Lovaza and require it to go through a whole new approval process with the FDA? Doesn't Vascepa have sufficient patent protection to prevent Lovaza from utilizing its active ingredient?

You also said that Amarin has been told to shut up and take it. Take what? Have they objected to this so called citizen petition? What are the consequences for them if they don't shut up?

Sorry for all the questions (actually I have a bunch more based on your postings today), but this is the first time I've seen anybody post such strongly worded accusations against the FDA and all the other players you mentioned.